<DOC>
	<DOCNO>NCT00809367</DOCNO>
	<brief_summary>The goal research study determine feasible collect leukemia cell patient ahead time ( undergo treatment ) cell ( radiate longer grow divide ) give back cancer vaccine if/after participant receive bone marrow blood stem cell transplant future . The purpose research study collect , freeze store leukemia call participant blood bone marrow . This study companion study vaccine study .</brief_summary>
	<brief_title>Collection Banking Leukemia Cells MDS/AML</brief_title>
	<detailed_description>- Leukemia cell collect one follow method : 1 ) Routine blood draw 2 ) Bone marrow aspirate 3 ) Leukapheresis . The physician study staff determine method best suit participant . - After collection , leukemia cell transport Cell Manipulation Core Facility ( CMCF ) Dana-Farber Cancer Institute , frozen time vaccine administration .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Patients AML eligible banking time relapse primary induction failure time AML diagnosis 60 year age old , AML arise background MDS MPD AML know high risk cytogenetics Patients MDSRAEB1 RAEBII , CMML1 CMMLII Patients must &gt; 5 % blast bone marrow peripheral blood ECOG Performance Status 02 Age great equal 18 year Reasonable likelihood , physician 's opinion , patient candidate allogeneic stem cell transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>MDS</keyword>
	<keyword>AML</keyword>
	<keyword>banking study</keyword>
</DOC>